Selection of chromosomal DNA libraries using a multiplex CRISPR system

  1. Owen W Ryan
  2. Jeffrey M Skerker
  3. Matthew J Maurer
  4. Xin Li
  5. Jordan C Tsai
  6. Snigdha Poddar
  7. Michael E Lee
  8. Will DeLoache
  9. John E Dueber
  10. Adam P Arkin
  11. Jamie H D Cate  Is a corresponding author
  1. BP Biofuels Global Technology Center, United States
  2. Energy Biosciences Institute, University of California, Berkeley, United States

Abstract

The directed evolution of biomolecules to improve or change their activity is central to many engineering and synthetic biology efforts. However, selecting improved variants from gene libraries in living cells requires plasmid expression systems that suffer from variable copy number effects, or the use of complex marker-dependent chromosomal integration strategies. We developed quantitative gene assembly and DNA library insertion into the Saccharomyces cerevisiae genome by optimizing an efficient single-step and marker-free genome editing system using CRISPR-Cas9. With this Multiplex CRISPR (CRISPRm) system, we selected an improved cellobiose utilization pathway in diploid yeast in a single round of mutagenesis and selection, which increased cellobiose fermentation rates by over ten-fold. Mutations recovered in the best cellodextrin transporters reveal synergy between substrate binding and transporter dynamics, and demonstrate the power of CRISPRm to accelerate selection experiments and discoveries of the molecular determinants that enhance biomolecule function.

Article and author information

Author details

  1. Owen W Ryan

    BP Biofuels Global Technology Center, San Diego, United States
    Competing interests
    Owen W Ryan, A patent application related to this work has been filed by J. Cate and O. Ryan on behalf of the Regents of the University of California.
  2. Jeffrey M Skerker

    Energy Biosciences Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  3. Matthew J Maurer

    Energy Biosciences Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  4. Xin Li

    Energy Biosciences Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  5. Jordan C Tsai

    Energy Biosciences Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  6. Snigdha Poddar

    Energy Biosciences Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  7. Michael E Lee

    Energy Biosciences Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  8. Will DeLoache

    Energy Biosciences Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  9. John E Dueber

    Energy Biosciences Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  10. Adam P Arkin

    Energy Biosciences Institute, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  11. Jamie H D Cate

    Energy Biosciences Institute, University of California, Berkeley, Berkeley, United States
    For correspondence
    jcate@lbl.gov
    Competing interests
    Jamie H D Cate, A patent application related to this work has been filed by J. Cate and O. Ryan on behalf of the Regents of the University of California.

Copyright

© 2014, Ryan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 13,579
    views
  • 2,558
    downloads
  • 313
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Owen W Ryan
  2. Jeffrey M Skerker
  3. Matthew J Maurer
  4. Xin Li
  5. Jordan C Tsai
  6. Snigdha Poddar
  7. Michael E Lee
  8. Will DeLoache
  9. John E Dueber
  10. Adam P Arkin
  11. Jamie H D Cate
(2014)
Selection of chromosomal DNA libraries using a multiplex CRISPR system
eLife 3:e03703.
https://doi.org/10.7554/eLife.03703

Share this article

https://doi.org/10.7554/eLife.03703

Further reading

    1. Chromosomes and Gene Expression
    2. Structural Biology and Molecular Biophysics
    Liza Dahal, Thomas GW Graham ... Xavier Darzacq
    Research Article

    Type II nuclear receptors (T2NRs) require heterodimerization with a common partner, the retinoid X receptor (RXR), to bind cognate DNA recognition sites in chromatin. Based on previous biochemical and overexpression studies, binding of T2NRs to chromatin is proposed to be regulated by competition for a limiting pool of the core RXR subunit. However, this mechanism has not yet been tested for endogenous proteins in live cells. Using single-molecule tracking (SMT) and proximity-assisted photoactivation (PAPA), we monitored interactions between endogenously tagged RXR and retinoic acid receptor (RAR) in live cells. Unexpectedly, we find that higher expression of RAR, but not RXR, increases heterodimerization and chromatin binding in U2OS cells. This surprising finding indicates the limiting factor is not RXR but likely its cadre of obligate dimer binding partners. SMT and PAPA thus provide a direct way to probe which components are functionally limiting within a complex TF interaction network providing new insights into mechanisms of gene regulation in vivo with implications for drug development targeting nuclear receptors.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Angel D'Oliviera, Xuhang Dai ... Jeffrey S Mugridge
    Research Article

    The SARS-CoV-2 main protease (Mpro or Nsp5) is critical for production of viral proteins during infection and, like many viral proteases, also targets host proteins to subvert their cellular functions. Here, we show that the human tRNA methyltransferase TRMT1 is recognized and cleaved by SARS-CoV-2 Mpro. TRMT1 installs the N2,N2-dimethylguanosine (m2,2G) modification on mammalian tRNAs, which promotes cellular protein synthesis and redox homeostasis. We find that Mpro can cleave endogenous TRMT1 in human cell lysate, resulting in removal of the TRMT1 zinc finger domain. Evolutionary analysis shows the TRMT1 cleavage site is highly conserved in mammals, except in Muroidea, where TRMT1 is likely resistant to cleavage. TRMT1 proteolysis results in reduced tRNA binding and elimination of tRNA methyltransferase activity. We also determined the structure of an Mpro-TRMT1 peptide complex that shows how TRMT1 engages the Mpro active site in an uncommon substrate binding conformation. Finally, enzymology and molecular dynamics simulations indicate that kinetic discrimination occurs during a later step of Mpro-mediated proteolysis following substrate binding. Together, these data provide new insights into substrate recognition by SARS-CoV-2 Mpro that could help guide future antiviral therapeutic development and show how proteolysis of TRMT1 during SARS-CoV-2 infection impairs both TRMT1 tRNA binding and tRNA modification activity to disrupt host translation and potentially impact COVID-19 pathogenesis or phenotypes.